UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are substantially ...
Hosted on MSN
DAP Health begins administering new twice-yearly HIV prevention medication. What to know
Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...
Add Yahoo as a preferred source to see more of our stories on Google. Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results